People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synereca Pharmaceuticals, Inc. | — | Biotech / Pharma | Pre-Seed | $900K | $30.7M | 2010 |
Clayton I. Duncan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Clayton I. Duncan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| W Bennett Love | 1 | 1 |
| Scott Singleton | 1 | 1 |
| Richard W Reichow | 1 | 1 |
| Bennett W. Love | 1 | 1 |
| Scott F. Singleton | 1 | 1 |
| Mark I. Corrigan | 1 | 1 |
| Richard E. Gammans | 1 | 1 |
| Scott I. Meacham | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.